Microscopic Versus Endoscopic Tympanoplasty

Tympanic Membrane Perforation Clinical Trial

Official title:

Tragal Cartilage Graft Tympanoplasty: Microscopic Versus Endoscopic

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06257602
• Other study ID #: Endoscopic tympanoplasty
• Status: Not yet recruiting
• Start date: March 30, 2024
• Est. completion date: December 30, 2025

Study information

• Verified date: February 2024
• Source: Assiut University
• Contact: Rania T Fahmi, Physcian
• Phone: 01203211138
• Email: ranoo4tharwt93[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In this study, The investigatirs will compare surgical and anatomical outcomes of endoscopic and microscopic tympanoplasty type 1(myringoplasty) using tragal perichondrum and cartilage, and conduct a post-treatment survey regarding: 1. Graft uptake, hearing outcome, postoperative pain, and healing time. 2. Assess the operation time.

Description:

Tympanic membrane perforation repair or tympanoplasty is a successful technique and has been validated in numerous studies since Wullstein and Zollner first proposed it in 1952. Previously, the technique was performed with illumination and magnification under a microscope. It typically requires an extensive postauricular incision to get through the narrow and curved external auditory canal, especially in child, complex perforations. The exclusive transcanal endoscopic tympanoplasty technique emerged in the 1990s; it provides more direct and wider surgical viewing angle, and it largely reduces the necessity for a traumatic postauricular incision in difficult cases. It has been gaining ground rapidly in recent years. Although closure rates tympanoplasty surgery can reach 90% or more, higher failure rates are seen in children, larger perforations, chronic Eustachian tube dysfunction, and in bilateral cases. Postoperative improvement in hearing is closely related to the postoperative change in the tympanogram. Postoperative hearing results and tympanograms are mainly influenced by the mucosal condition of the Eustachian tube (ET) orifice. Relatively greater improvement in hearing is observed in the long-term follow- up. Different graft materials have been proposed over the years to improve surgical outcomes, the search for an ideal graft is a subject of continued discussion, as transcanal endoscopic approaches have been proposed for larger and more complex perforations once reserved for postauricular techniques. The temporalis fascia (TF) has been the most preferred graft material for conventional microscopic tympanoplasty via postauricular or endaural approaches; it has theadvantages of having a readily available and plentiful source, and though its durability has been challenged in recent years, it is still widely used. However, with the increasing popularity of transcanal endoscopic ear surgery (TEES), an increasing number of otologists have adopted this technique and switched to using the nearby tragal perichondrium/cartilage graft when the surgical route is changed. The tragus has a pivotal function in reconstruction in ear surgery, and it is limited in source; hence, harvest on an ad hoc basis may lead to donor insufficiency at ensuing surgeries. Moreover, the tragus constitutes the anterior cartilaginous skeleton of the EAM and plays a role in sound transmission; maintaining its integrity would benefit future hearing device applications.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 80
• Est. completion date: December 30, 2025
• Est. primary completion date: November 30, 2025
• Gender: All
• Age group: 15 Years to 45 Years

Eligibility

Inclusion Criteria:

• Inactive chronic tubotympanic otitis media (dry ear: no otorrhea without medication for at least 1 month).
• Patients with age 15-45 years old in both sexes.
• Patients with pure conductive hearing loss. unhealed tympanic membrane perforation for >3 months.
• Patients who are willing to give consent for the study.

Exclusion Criteria:

• Deeper lesions (Attico-antral disease, ossiculopathy, atelectasis, cholesteatoma, etc.), if suspected, on computed tomography scan.
• Patients below 15 years old, and more than 45 years old.
• Previous tympanoplasty, or other ear surgery.
• Sensori- neural hearing loss.
• Discharging ear.
• Narrow obvious narrowing of the EAC or syndromes that affect the middle ear (e.g., Down syndrome). 7) Comorbid systemic diseases like diabetes or any chronic specific infection.

Related Conditions & MeSH terms

• Tympanic Membrane Perforation

Intervention

Procedure:
• Tragal graft tympanoplasty
Comparison study between Endoscopic and microscopic tympanoplasty using tragal graft

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

References & Publications (1)

Thomassin JM, Duchon-Doris JM, Emram B, Rud C, Conciatori J, Vilcoq P. [Endoscopic ear surgery. Initial evaluation]. Ann Otolaryngol Chir Cervicofac. 1990;107(8):564-70. French. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tragal cartilage graft tympanoplasty: Microscopic versus endoscopic	Time taken during surgery in microscopic tympanoplasty versus time taken during endoscopic tympanoplasty in minutes	24 months